Massachusetts General Hospital (MGH) Fertility Center is the reproductive endocrinology and infertility program affiliated with Massachusetts General Hospital, a teaching hospital of Harvard Medical School. Located in Boston, Massachusetts, the MGH Fertility Center is one of the premier academic fertility programs in the United States, combining leading-edge research with patient-centered clinical care. The program serves patients from Boston, the surrounding Greater Boston region, and beyond — including patients who travel from other states and internationally for care. Massachusetts has a comprehensive fertility insurance mandate, and MGH Fertility Center participates with qualifying plans. For a full listing of fertility resources across the Commonwealth, see our Massachusetts fertility clinics directory.
Physicians and Clinical Team
MGH Fertility Center is staffed by reproductive endocrinologists who hold faculty appointments at Harvard Medical School. The physicians are board-certified in obstetrics and gynecology with subspecialty board certification in reproductive endocrinology and infertility, and many are internationally recognized researchers in fields including ovarian biology, embryo implantation, recurrent pregnancy loss, and polycystic ovary syndrome. The team includes reproductive endocrinology fellows training under faculty supervision, registered nurses with fertility specialization, embryologists with clinical embryology certification, licensed genetic counselors, and patient care coordinators. The multidisciplinary Harvard Medical School environment provides access to expertise across oncology, genetics, maternal-fetal medicine, and surgery when complex cases require it.
Services and Treatments
MGH Fertility Center provides the following services:
- Comprehensive fertility evaluation — complete hormonal assessment, antral follicle count, hysterosalpingography, saline infusion sonography, semen analysis, and genetic screening
- Ovulation induction — oral and injectable protocols with cycle monitoring
- Intrauterine insemination (IUI)
- In vitro fertilization (IVF) — conventional, minimal stimulation, and natural cycle protocols
- Intracytoplasmic sperm injection (ICSI)
- Preimplantation genetic testing (PGT-A and PGT-M) — chromosomal and single-gene disorder screening
- Frozen embryo transfer (FET)
- Fertility preservation — oocyte and embryo cryopreservation for elective and oncofertility purposes
- Third-party reproduction — donor egg, donor sperm, and gestational carrier coordination
- Recurrent pregnancy loss evaluation — including immunologic, anatomic, genetic, and thrombophilic workup
- Male fertility evaluation — in partnership with MGH urology
- Oncofertility — urgent fertility preservation for patients facing cancer treatment
- Reproductive surgery — hysteroscopic and laparoscopic procedures for uterine and tubal conditions
Laboratory and Success Rates
The MGH Fertility Center's IVF laboratory operates at the highest level of academic and clinical excellence. The lab employs vitrification for cryopreservation, time-lapse embryo imaging, extended blastocyst culture, and rigorous quality control systems. Research conducted within the lab and by affiliated faculty at Harvard informs ongoing improvements to culture conditions, cryopreservation, and embryo selection. MGH reports outcomes to SART.
Patients should review the most current cycle-level data published by the CDC's ART Surveillance program and the SART Clinic Summary Report.
Patient Experience
Patients at MGH Fertility Center receive care within one of the world's great academic medical centers. The Boston campus offers access to the full resources of Massachusetts General Hospital, including endocrinology, oncology, genetics, maternal-fetal medicine, and urology under one roof. This is particularly valuable for patients with complex or unusual diagnoses. The clinical team works to provide high-touch patient support despite the academic environment, with nursing staff maintaining communication throughout treatment cycles. Wait times for new patient consultations can be longer than at private practices; prospective patients are encouraged to call early and ask about scheduling options.
Considering At-Home Insemination?
Not every fertility journey begins in a clinic. For individuals and couples exploring their options before pursuing formal medical treatment — or those working with a known sperm donor — at-home insemination kits offer a private, lower-cost first step. MakeAMom offers FDA-cleared at-home insemination systems designed for a variety of needs: the CryoBaby kit works with frozen or low-volume sperm, the Impregnator kit is optimized for low motility sperm, and the BabyMaker kit is designed for users with sensitivities or conditions such as vaginismus. All kits are reusable and shipped in plain, discreet packaging. MakeAMom reports an average 67% success rate among clients who use their home insemination systems. At-home insemination is not a replacement for medical care when underlying conditions are present, but it can be a meaningful starting point — and knowing when to consult a board-certified reproductive endocrinologist is the right next step.
Insurance and Financing
Massachusetts has a strong fertility insurance mandate requiring most state-regulated group health insurance plans to cover the diagnosis and treatment of infertility, including IVF. MGH Fertility Center participates with a wide range of insurance plans and the financial counseling team can assist with benefit verification, prior authorization, and patient-specific coverage questions.
As a Harvard-affiliated hospital, MGH also participates in financial assistance programs for qualifying patients and can connect patients with medical financing resources for services not covered by insurance.
Other mandate states: New York, New Jersey, Connecticut, Illinois, Maryland, and Rhode Island also require insurers to cover IVF and related treatments.
Frequently Asked Questions
Is MGH Fertility Center affiliated with Harvard Medical School? Yes. Massachusetts General Hospital is a primary teaching hospital of Harvard Medical School. The reproductive endocrinology faculty at MGH hold appointments at Harvard, and the clinical program operates within the Harvard Medical School affiliated hospitals network.
Does MGH see patients who have failed IVF at other clinics? Yes. Patients who have experienced prior IVF failures, recurrent implantation failure, or unexplained recurrent pregnancy loss are frequently referred to or self-refer to MGH for second opinions or further evaluation. The academic environment and research expertise can be particularly valuable for these patients.
How does MGH coordinate oncofertility care? MGH Fertility Center works closely with MGH's oncology department to provide urgent fertility preservation consultations for newly diagnosed cancer patients. The goal is to perform egg or embryo freezing before cancer treatment begins. The program has established pathways to expedite the process when time before treatment is limited.
Can I receive remote consultations with MGH physicians? MGH offers telehealth consultation options for new and established patients in appropriate circumstances. Initial consultations may be available via telehealth, though in-person visits will typically be required for physical examination, ultrasound, and procedures. Contact the clinic to ask about telehealth availability for your specific situation.